β-Nicotinamide adenine dinucleotide, reduced form, disodium salt (β-NADH)
| Post Date: |
Dec 20,2021 |
| Expiry Date: |
Jun 18,2022 |
| Detailed Description: |
Cas No. :606-68-8
|
| CAS Registry Number: |
|
| Synonyms: |
;disodium [(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methyl [[(2R,3S,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methoxy-oxido-phosphoryl] phosphate;NADH;beta-Nicotinamide adenine dinucleotide disodium salt;β-NADH;β-Nicotinamide adenine dinucleotide disodium salt; |
| Molecular Formula: |
C21H26N7Na2O14P2 |
| Molecular Weight: |
708.3962 |
| Molecular Structure: |
|
| Safety Description: |
S24/25:;
|
| Company: |
H&B Pharm-Tech Co.,Ltd.
[ China ]
|
| Contact: |
Jackie Chan |
| Tel: |
+86 189 5415 5098 |
| Fax: |
info@hbpharmtech.com |
| Email: |
info@hbpharmtech.com |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.
